These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9298040)

  • 1. Recipient selection and management before cardiac transplantation.
    Frantz RP; Olson LJ
    Am J Med Sci; 1997 Sep; 314(3):139-52. PubMed ID: 9298040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic features in patients with congestive heart failure and selection criteria for cardiac transplantation.
    Edwards BS; Rodeheffer RJ
    Mayo Clin Proc; 1992 May; 67(5):485-92. PubMed ID: 1405777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart transplantation: who should be considered and when?
    Macdonald P
    Intern Med J; 2008 Dec; 38(12):911-7. PubMed ID: 19120548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac transplantation: the final therapeutic option for the treatment of heart failure.
    Koerner MM; Durand JB; Lafuente JA; Noon GP; Torre-Amione G
    Curr Opin Cardiol; 2000 May; 15(3):178-82. PubMed ID: 10952425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pre-transplant evaluation: which patients for the active list?].
    Soares RM
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():59-65. PubMed ID: 11409075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK guidelines for referral and assessment of adults for heart transplantation.
    Banner NR; Bonser RS; Clark AL; Clark S; Cowburn PJ; Gardner RS; Kalra PR; McDonagh T; Rogers CA; Swan L; Parameshwar J; Thomas HL; Williams SG
    Heart; 2011 Sep; 97(18):1520-7. PubMed ID: 21856726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical therapy of end-stage heart failure. State of the art 2006].
    Klotz S; Loeher A; Drees G; Scheld HH
    Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term management of end-stage heart failure.
    Habal MV; Garan AR
    Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):153-166. PubMed ID: 29110789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure.
    Frigerio M; Gronda EG; Mangiavacchi M; Andreuzzi B; Colombo T; De Vita C; Oliva F; Quaini E; Pellegrini A
    J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
    Younes A; Al-Kindi SG; Alajaji W; Mackall JA; Oliveira GH
    Int J Cardiol; 2017 Mar; 231():211-215. PubMed ID: 28043679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal heart failure: who should be transplanted and who should have mechanical circulatory support?
    Kirklin JK
    Curr Opin Organ Transplant; 2014 Oct; 19(5):486-93. PubMed ID: 25186823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of the art in heart transplantation.
    Anand J; R Mallidi H
    Semin Thorac Cardiovasc Surg; 2013; 25(1):64-9. PubMed ID: 23800530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe right ventricular dysfunction is an independent predictor of pre- and post-transplant mortality among candidates for heart transplantation.
    Ravis E; Theron A; Mancini J; Jaussaud N; Morera P; Chalvignac V; Guidon C; Grisoli D; Gariboldi V; Riberi A; Habib G; Mouly-Bandini A; Collart F
    Arch Cardiovasc Dis; 2017 Mar; 110(3):139-148. PubMed ID: 28117247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list.
    Jeewa A; Manlhiot C; Kantor PF; Mital S; McCrindle BW; Dipchand AI
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):462-8. PubMed ID: 24183905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and management of potential heart transplant recipients.
    Jessup M; Brozena SC
    Cardiol Clin; 1990 Feb; 8(1):11-21. PubMed ID: 2407353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
    Jong P; Yusuf S; Rousseau MF; Ahn SA; Bangdiwala SI
    Lancet; 2003 May; 361(9372):1843-8. PubMed ID: 12788569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart transplantation an answer for end-stage heart failure.
    Smith L; Farroni J; Baillie BR; Haynes H
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):489-94. PubMed ID: 14717394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac transplantation as a treatment option for the heart failure patient.
    Tokarczyk TR
    Crit Care Nurs Q; 2003; 26(1):61-8. PubMed ID: 12669949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J
    J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.